ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026
Volume retention after left atrial appendage occlusion: incidence and risk factors.
Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe LAA secretes ANP which has neurohormonal effects on fluid balance, but the effects of left atrial appendage occlusion (LAAO) on clinical volume status remains uncertain.
methodsWe compared patients who underwent LAAO with Watchman 2.5 (n = 151, 38% female) and Watchman FLX (n = 80, 31% female) to a control group with AF without LAAO (n = 186, 38% female). Clinical data was manually extracted from the EMR. Progressive volume retention was defined as initiation or increase in diuretic dose within 12 months of LAAO, or within last 12 months from most recent cardiology visit for controls.
resultsA total of 49/231 (21.2%) of the LAAO cohort showed a rise in loop diuretic requirements compared to 27/186 (14.5%) of the controls (p = 0.078). There were 17/231 (7.4%) new diuretic prescriptions in the LAAO group compared to 6/186 (3.2%) for the controls (p = 0.066). In a multivariable model, only age, prior HF, and LAAO predicted a rise in loop diuretic use. The strongest predictors were presence of prior HF, OR 2.32 (95% CI 1.28-4.21, p = 0.005) and LAAO, OR 1.9 (95% CI 1.09-3.27, p = 0.023). Within the LAAO cohort, larger LAA size was the strongest predictor of symptomatic HF.
conclusionsThese results suggest that LAAO is associated with an almost twofold increased risk of volume retention. This risk is highest among patients with HF and larger LAAs. These findings may inform pre-implantation discussions and post-LAAO management.
Indexed as
Identifiers
41385172What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.